Solural Pharma ApS has received a decision to grant a Eurasia patent for the patent “Solid Oral Dosage Form of Lipophilic Compounds”.
Solural Pharma receives an updated Manufacturing and Importation Authorisation from the Danish Health and Medicines Authority expanding its manufacturing capabilities to also include manufacturing of inhalation products as well as for physical chemical testing of...
The European Patent office has announced a decision to grant Solural Pharma a European patent “Solid Oral Dosage Form of Lipophilic Compounds”.
Solural Pharma receives approval from the Danish Health and Medicinal Authorities for handling Cannabis products with the aim to develop new medicinal products.
Solural Pharma ApS has entered into a cooperation agreement to develop new improved Medicinal Cannabis Products based on the Solural Technology.